{"title": "COVID-19 tracker: US life expectancy falls again; AZ's Evusheld nabs treatment nod", "author": "Zoey Becker; Kevin Dunleavy; Fraiser Kansteiner; Angus Liu", "url": "https://www.fiercepharma.com/pharma/covid-19-tracker-pfizer-targets-variant-specific-vaccines-fall", "hostname": "fiercepharma.com", "description": "Due to drug overdoses and COVID-19 deaths, life expectancy in the U.S. has dropped for the second straight year. | Due to drug overdoses and COVID-19 deaths, life expectancy in the U.S. has dropped for the second straight year. Japan has become the first nation to sanction the use of AstraZeneca's Evusheld as a treatment for those infected with COVID-19. And more.", "sitename": "FiercePharma", "date": "2022-08-31", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}